Burning Rock Biotech Limited (BNR)

EBITDA Margin

-8.43%

TTM · Period ending:

BNR logo

BNR EBITDA Margin

Latest reported-8.43%
BNR TTM EBITDA Margin (-24.45% → -8.43%)
High-resolution chart · PNG

BNR ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Burning Rock Biotech Limited EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-8.4343%
-6.5282%
-5.4922%
-9.4572%
-11.9514%
-31.5033%
-51.4993%
-57.4942%
-84.232%
-85.1851%
-93.974%
-119.598%
-123.9411%
-150.3836%
-165.4851%
-163.864%
-160.969%
-148.3086%
-139.7186%
-132.3367%
-123.9587%
-104.9348%
-86.5957%
-82.6984%
-61.6672%
-51.6737%
-36.4117%
-24.4517%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.